logo-loader

Futura Medical PLC

Receive alerts
Market:
AIM
Market Cap:
£71.43 m
Price
34.90 GBX
Change
7.38%
52 weeks high
47.90
52 weeks low
5.65

In brief

Futura Medical is an innovative R&D company with a pipeline of products in late stage development. We are experts in transdermal delivery and have developed an advanced proprietary transdermal technology, DermaSys®. Our lead product MED2005, is a breakthrough topical treatment for erectile dysfunction currently in Phase 3 clinical trial with potential peak sales of $1bn1. Our strategy is to develop our innovative product portfolio to late stage and then to partner with major pharmaceutical partners. We are based in Guildford, UK and are listed on the AIM market of the London Stock Exchange.

Deep dive We explore the investor case for growth companies

Snapshot

  • Focus on MED2005 ED gel and TPR100 pain relief gel
  • Based on its DermaSys skin-based drug delivery system
  • MED2005 phase III trial results due by end of year
  • Seeking UK approval for TPR100